Resolution of Pediococcus acidilactici bacteremia without antibiotic therapy in a 16-year-old adolescent with leukemia receiving maintenance chemotherapy. (2022)

• Record Type: Journal Article
• Authors: Tachikawa, Jun; Aizawa, Yuta; Izumita, Ryohei; Shin, Chansu; Imai, Chihaya; Saitoh, Akihiko
• Is Part Of: IDCases. Volume 27(2022)
• Publication Date: 2022
• Subjects: Bacteremia -- Colitis -- Dasatinib -- Leukemia -- Pediococcus acidilactici; Communicable diseases -- Periodicals; Communicable Diseases -- Case Reports; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; 616.9
• DOI: 10.1016/j.idcr.2022.e01384
• Languages: English
• ISSNs: 2214-2509

Abstract

Highlights: P. acidilactici infection can be self-limiting, even in immunocompromised hosts. P. acidilactici infection can occur in dasatinib-induced hemorrhagic colitis. Dairy products consumers can cause P. acidilactici bacteremia. Abstract: Pediococcus spp. have been reported to cause infections in patients with underlying conditions. However, the pathogenicity of this bacteria is unclear. Herein, we describe the first case of Pediococcus acidilactici bacteremia, which occurred in a 16-year-old male with dasatinib-induced hemorrhagic colitis during maintenance therapy for leukemia and resolved without antibiotic treatment. P. acidilactici bacteremia might be self-limiting, even in immunocompromised patients receiving chemotherapy.